Syncore Biotechnology Co. Ltd. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 2.007 million compared to TWD 2.047 million a year ago. Operating loss was TWD 81.326 million compared to TWD 65.838 million a year ago. Net loss was TWD 80.816 million compared to TWD 64.284 million a year ago. Basic loss per share was TWD 1.02 compared to TWD 0.92 a year ago. For the nine months, sales was TWD 5.778 million compared to TWD 6.157 million a year ago. Operating loss was TWD 203.529 million compared to TWD 192.622 million a year ago. Net loss was TWD 201.874 million compared to TWD 190.324 million a year ago. Basic loss per share was TWD 2.75 compared to TWD 2.72 a year ago.